Verdane Invests in Clue to Accelerate Women’s Health Solutions

Clue, the top women-led period and cycle tracker health and wellness app with over 100 million downloads globally, has announced a major investment from Verdane, a European specialist growth equity firm on January 15, 2026. This investment, drawn from Verdane’s €2 billion growth fund, represents the largest financial commitment to Clue thus far and signifies a pivotal moment for the company.

The funding comes on the heels of a strong performance in 2025, which has laid a solid foundation for Clue’s growth and a clear trajectory toward sustainable profitability. Verdane’s investment positions it as the largest stakeholder in Clue, reflecting a shared vision between the two organizations regarding the importance of women’s health in the global wellness landscape.

Rhiannon White, CEO of Clue, emphasized the significance of this partnership, stating, “Women are the world’s largest health and wellness consumers, yet they remain strikingly underserved relative to their economic power. This gap creates systemic pain points, including a lack of accessible health knowledge and barriers to care.” She added that the collaboration with Verdane will enable Clue to accelerate the development of solutions that address these issues.

Verdane’s investment philosophy focuses on sustainable growth and operational excellence, aligning closely with Clue’s ambition to set a global standard in digital women’s health. Christina Stoll, Principal at Verdane, remarked, “Clue has earned exceptional user trust by combining the highest data protection standards with rigorous, science-based insights in a category where credibility truly matters.”

Clue’s commitment to medical research and ethical data practices has differentiated it in the crowded health app market. The app, available in 23 languages across over 190 countries, empowers users to track their cycles and make informed health decisions. With one of the largest datasets of menstrual health information, Clue collaborates with leading research institutions to advance women’s health knowledge.

Looking ahead, Clue and Verdane plan to invest in research, partnerships, and privacy-first technology to enhance user engagement and expand their market presence. The investment is expected to facilitate Clue’s entry into new health-related services and strengthen its position against competitors in the women’s health sector.

As the demand for trusted women’s health solutions continues to grow, Clue is well-positioned to lead the market, supported by Verdane’s expertise in scaling digital health platforms. This partnership not only aims to enhance Clue’s product offerings but also to create a more equitable health landscape for women worldwide.